Return to Article Details
MAL, a potential immunotherapy target, is associated with poor prognosis in cancer patients
Download
Download PDF
https://mail.cellmolbiol.org/index.php/CMB
Themes by Openjournaltheme.com
Themes by Openjournaltheme.com